KDM5A regulates the growth and gefitinib drug resistance against human lung adenocarcinoma cells
Author(s) -
Hong Wu,
Lidong Xu,
Xun Hu
Publication year - 2022
Publication title -
3 biotech
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.557
H-Index - 37
eISSN - 2190-572X
pISSN - 2190-5738
DOI - 10.1007/s13205-021-03018-w
Subject(s) - adenocarcinoma , cancer research , downregulation and upregulation , gene knockdown , gene silencing , gefitinib , lung cancer , cell growth , apoptosis , cell culture , biology , medicine , cancer , pathology , gene , biochemistry , genetics , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom